Title : Characterization of precursor and secreted forms of human angiotensinogen.

Pub. Date : 1985 Jun

PMID : 2989336






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Tunicamycin-treated Hep G2 cells secreted five discrete forms of angiotensinogen, a predominant form of mol wt 46,200, with other forms (mol wt 46,800, 48,100, 49,200, and 49,600) representing 10% of secreted angiotensinogen. Tunicamycin angiotensinogen Homo sapiens
2 Tunicamycin-treated Hep G2 cells secreted five discrete forms of angiotensinogen, a predominant form of mol wt 46,200, with other forms (mol wt 46,800, 48,100, 49,200, and 49,600) representing 10% of secreted angiotensinogen. Tunicamycin angiotensinogen Homo sapiens
3 The other higher molecular weight forms of angiotensinogen secreted by tunicamycin-treated Hep G2 cells were shown to represent O-glycosylated angiotensinogen in that they were reduced to 46,200 mol wt by treatment with trifluoromethane sulfonic acid. Tunicamycin angiotensinogen Homo sapiens
4 The other higher molecular weight forms of angiotensinogen secreted by tunicamycin-treated Hep G2 cells were shown to represent O-glycosylated angiotensinogen in that they were reduced to 46,200 mol wt by treatment with trifluoromethane sulfonic acid. Tunicamycin angiotensinogen Homo sapiens